Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1 - Test2 - elhamkhani - TriplyDB

Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1

Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1

http://www.wikidata.org/entity/Q28268301

about

Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists The dopamine metabolite 3-methoxytyramine is a neuromodulator Trace amine-associated receptors as emerging therapeutic targets The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain Trace amine-associated receptor 1-Family archetype or iconoclast?Trace amine-associated receptor 1 as a monoaminergic modulator in brain Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications Commonalities and Distinctions Among Mechanisms of Addiction to Alcohol and Other Drugs Ractopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1 Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5 "TAARgeting Addiction"--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference Determinants involved in subtype-specific functions of rat trace amine-associated receptors 1 and 4 An amphetamine isomer whose efficacy and safety in humans has never been studied, β-methylphenylethylamine (BMPEA), is found in multiple dietary supplements Functional evolution of the trace amine associated receptors in mammals and the loss of TAAR1 in dogs.Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut-From Gut to Brain?Structural and functional evolution of the trace amine-associated receptors TAAR3, TAAR4 and TAAR5 in primates.New insights into the structure of the trace amine-associated receptor 2: Homology modelling studies exploring the binding mode of 3-iodothyronamine.Human Mas-related G protein-coupled receptors-X1 induce chemokine receptor 2 expression in rat dorsal root ganglia neurons and release of chemokine ligand 2 from the human LAD-2 mast cell line Are Caenorhabditis elegans receptors useful targets for drug discovery: pharmacological comparison of tyramine receptors with high identity from C. elegans (TYRA-2) and Brugia malayi (Bm4).Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association.The molecular basis of species-specific ligand activation of trace amine-associated receptor 1 (TAAR(1)).Toward deciphering the code to aminergic G protein-coupled receptor drug design.Targeting species-specific trace amine-associated receptor 1 ligands: to date perspective of the rational drug design process.Structure-activity correlations for beta-phenethylamines at human trace amine receptor 1.Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1.Investigation of Naturally Occurring Single-Nucleotide Variants in Human TAAR1.The Case for TAAR1 as a Modulator of Central Nervous System Function.

P2860

Q21090974-59FEE6F2-B131-446D-BAF2-1EC4951E59E6 Q21091097-F4DBD7C3-E3E9-484E-A24C-94E1E7BD5E5C Q22242286-9A9E580C-FFDA-4E13-B581-F3B09950989B Q22242368-7558C635-CC8C-428E-8D59-6EA21208E6CA Q22252340-FA6A7E12-7044-4D15-830E-DD34E7520951 Q24627304-F6C10631-9B16-4324-A824-3C8BD642FA4A Q24634650-8F786DA5-B57D-4692-9F1E-5B86271B7781 Q24642179-05714964-59BB-4826-A8D7-0DEE7FE860DB Q24648659-957B4024-9DB6-4395-9D7B-315B4C026BA0 Q24650242-EBA1C1F4-CBFA-402A-AF42-C72E76891B90 Q26752602-06EC0F7C-BD52-4611-8282-621D0B35F93F Q28080974-8DCD426D-05BA-4A5A-97EB-F98981945992 Q28239596-F45F7275-09CB-41EB-B48F-22926EFD6A88 Q28257584-7609A219-15CA-4C64-9C73-DB67D53C68B3 Q28270706-09B8A98D-E812-4C05-90DA-8E6F2256B696 Q28704020-A3930FA2-D588-469C-A550-B6E4C7DEAFA3 Q29039892-E5D7A641-A6B6-4CEB-BAA6-2465A8144A07 Q33532292-F72CD0DC-38FF-4DED-B5B3-F09EF5C5E03B Q33742405-D9510C99-DD96-435B-81F6-EAEA7C275816 Q33915158-B4508D8C-80DF-4684-B658-75118D50E97E Q34545052-CCC8CACA-AEDA-490E-9C64-EC40CC2BCC01 Q34626038-4F778933-4345-4126-B6B6-74B4CF874DF8 Q36196893-6500F481-5D45-451F-8611-86F4CD8BC0CD Q36721077-9F09FDFB-BBFA-4806-9A25-A295C7C00FB8 Q36746446-011E6FB5-236C-4960-857E-5F345E8564A7 Q37101829-FE05F20D-4A8D-4059-B217-94758E804CA8 Q37179691-A7D4309B-AAAD-4387-BC12-2220ED9BE3C6 Q37269754-64833680-A35E-46C9-8BF7-C89A81D1CCF5 Q38644990-BCEA0966-B335-43C1-969F-ACBD77F27243 Q39964874-53FD86B7-A0E7-471B-A45F-239C5CB9124B Q41877712-7ACDE019-F648-4490-AE37-18522ABE9E81 Q46607679-353D4044-0342-4AE8-9FAE-9B1B95FD9D03 Q47131141-66D32BBC-4F14-4849-83B2-6F9EDDEE6800 Q47640093-34AC902C-C5C1-48E4-8EC2-0E6DC068C6EC

P2860

Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1

http://www.wikidata.org/entity/Q28268301

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Pharmacologic characterization ...... differences with the rat TAAR1

@ast

Pharmacologic characterization ...... differences with the rat TAAR1

@en

Pharmacologic characterization ...... differences with the rat TAAR1

@nl

type

label

Pharmacologic characterization ...... differences with the rat TAAR1

@ast

Pharmacologic characterization ...... differences with the rat TAAR1

@en

Pharmacologic characterization ...... differences with the rat TAAR1

@nl

prefLabel

Pharmacologic characterization ...... differences with the rat TAAR1

@ast

Pharmacologic characterization ...... differences with the rat TAAR1

@en

Pharmacologic characterization ...... differences with the rat TAAR1

@nl

P1433

Q28268301-B888C50B-A751-49CD-A898-E8D412C3B287

P1476

Q28268301-0BD44654-886B-4252-89E3-8A7E73232E9D

P2093

Q28268301-017A59AB-36B4-4D57-A3AA-DEF10EAEED8B

Q28268301-1B3DF583-86FC-405E-A209-4A397E3FBFF4

Q28268301-5302F471-A5C3-4F06-93A2-40A7F037AF6E

Q28268301-5A1316A2-4D5C-47E3-9B27-27163B291DAD

Q28268301-C4DB222A-3512-4FC9-8A65-7EBDBFA3650B

Q28268301-EA994FF2-AAE4-4C2D-BA44-25545877706B

Q28268301-F7891B35-6AEE-4DD2-92B4-81C725F9EDA1

P304

Q28268301-E956FEED-AF8C-4B63-A585-21AF7DA7F0F6

P31

Q28268301-B70EE223-E67B-4B4D-961B-9785E3DBE6B5

P3181

Q28268301-D189B2CB-F2DA-476B-BF99-447E81699AAA

P356

Q28268301-5DDB081B-1742-4158-A125-FBD80375A17A

P407

Q28268301-3257EDAF-4D77-45A7-A424-CE556A4EE904

P433

Q28268301-5F3FF4FD-CF42-4FD5-95D9-DE16F68E2780

P478

Q28268301-67495D3B-8476-430E-B300-59924A5F6F9F

P577

Q28268301-09E1A16B-0BE5-4813-8002-3FD7963FE97F

P698

Q28268301-71C630CD-4BDF-48E9-A344-22CD46C40A27

P921

Q28268301-88E22631-138E-4043-A3D2-CAA633ACE4F6

P3181

P356

JPET.106.112532

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Pharmacologic characterization ...... differences with the rat TAAR1

@en

P2093

David B Wainscott

http://www.w3.org/2001/XMLSchema#string

David L Nelson

http://www.w3.org/2001/XMLSchema#string

John X He

http://www.w3.org/2001/XMLSchema#string

Sheila P Little

http://www.w3.org/2001/XMLSchema#string

Tinggui Yin

http://www.w3.org/2001/XMLSchema#string

Vincent P Rocco

http://www.w3.org/2001/XMLSchema#string

Yuan Tu

http://www.w3.org/2001/XMLSchema#string

P304

475-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2471422

http://www.w3.org/2001/XMLSchema#string

P356

10.1124/JPET.106.112532

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

320

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17038507

http://www.w3.org/2001/XMLSchema#string

P921